These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 38402504)
1. Urinary podocyte markers of disease activity, therapeutic efficacy, and long-term outcomes in acute and chronic kidney diseases. Fukuda A; Sato Y; Shibata H; Fujimoto S; Wiggins RC Clin Exp Nephrol; 2024 Jun; 28(6):496-504. PubMed ID: 38402504 [TBL] [Abstract][Full Text] [Related]
2. Urinary podocyte and TGF-β1 mRNA as markers for disease activity and progression in anti-glomerular basement membrane nephritis. Fukuda A; Minakawa A; Sato Y; Iwakiri T; Iwatsubo S; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S Nephrol Dial Transplant; 2017 Nov; 32(11):1818-1830. PubMed ID: 28419296 [TBL] [Abstract][Full Text] [Related]
3. Urinary and glomerular podocytes in patients with chronic kidney diseases. Hanamura K; Tojo A; Fujita T Clin Exp Nephrol; 2014 Feb; 18(1):95-103. PubMed ID: 23670304 [TBL] [Abstract][Full Text] [Related]
4. Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome. Ding F; Wickman L; Wang SQ; Zhang Y; Wang F; Afshinnia F; Hodgin J; Ding J; Wiggins RC Kidney Int; 2017 Dec; 92(6):1515-1525. PubMed ID: 28754557 [TBL] [Abstract][Full Text] [Related]
5. [The role of podocyte injury in chronic kidney disease]. Asanuma K Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686 [TBL] [Abstract][Full Text] [Related]
6. Urine podocyte mRNAs mark progression of renal disease. Sato Y; Wharram BL; Lee SK; Wickman L; Goyal M; Venkatareddy M; Chang JW; Wiggins JE; Lienczewski C; Kretzler M; Wiggins RC J Am Soc Nephrol; 2009 May; 20(5):1041-52. PubMed ID: 19389856 [TBL] [Abstract][Full Text] [Related]
7. Increasing urinary podocyte mRNA excretion and progressive podocyte loss in kidney contribute to the high risk of long-term renal disease caused by preterm birth. Ding F; Gao Q; Tian X; Mo J; Zheng J Sci Rep; 2021 Oct; 11(1):20650. PubMed ID: 34667204 [TBL] [Abstract][Full Text] [Related]
8. Urine podocyte mRNAs mark disease activity in IgA nephropathy. Fukuda A; Sato Y; Iwakiri T; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757 [TBL] [Abstract][Full Text] [Related]
9. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. Wickman L; Afshinnia F; Wang SQ; Yang Y; Wang F; Chowdhury M; Graham D; Hawkins J; Nishizono R; Tanzer M; Wiggins J; Escobar GA; Rovin B; Song P; Gipson D; Kershaw D; Wiggins RC J Am Soc Nephrol; 2013 Dec; 24(12):2081-95. PubMed ID: 24052633 [TBL] [Abstract][Full Text] [Related]
10. Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker. Fukuda A; Wickman LT; Venkatareddy MP; Wang SQ; Chowdhury MA; Wiggins JE; Shedden KA; Wiggins RC Nephrol Dial Transplant; 2012 Nov; 27(11):4079-87. PubMed ID: 22863839 [TBL] [Abstract][Full Text] [Related]
11. Urine synaptopodin excretion is an important marker of glomerular disease progression. Kwon SK; Kim SJ; Kim HY Korean J Intern Med; 2016 Sep; 31(5):938-43. PubMed ID: 27604800 [TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria. Zhou L; Chen X; Lu M; Wu Q; Yuan Q; Hu C; Miao J; Zhang Y; Li H; Hou FF; Nie J; Liu Y Kidney Int; 2019 Apr; 95(4):830-845. PubMed ID: 30770219 [TBL] [Abstract][Full Text] [Related]
13. Excretion Patterns of Urinary Sediment and Supernatant Podocyte Biomarkers in Patients with CKD. Fukuda A; Minakawa A; Sato Y; Shibata H; Hara M; Fujimoto S Kidney360; 2022 Jan; 3(1):63-73. PubMed ID: 35368571 [TBL] [Abstract][Full Text] [Related]
14. Podocyte hypertrophic stress and detachment precedes hyperglycemia or albuminuria in a rat model of obesity and type2 diabetes-associated nephropathy. Minakawa A; Fukuda A; Sato Y; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S Sci Rep; 2019 Dec; 9(1):18485. PubMed ID: 31811176 [TBL] [Abstract][Full Text] [Related]
15. Nephron deficit and low podocyte density increase risk of albuminuria and glomerulosclerosis in a model of diabetes. Gazzard SE; van der Wolde J; Haruhara K; Bertram JF; Cullen-McEwen LA Physiol Rep; 2023 Jan; 11(2):e15579. PubMed ID: 36695822 [TBL] [Abstract][Full Text] [Related]
16. Urinary Markers of Podocyte Dysfunction in Chronic Glomerulonephritis. Chebotareva N; Bobkova I; Lysenko L; Moiseev S Adv Exp Med Biol; 2021; 1306():81-99. PubMed ID: 33959907 [TBL] [Abstract][Full Text] [Related]
17. Detection of urinary podocytes and nephrin as markers for children with glomerular diseases. Wang P; Li M; Liu Q; Chen B; Ji Z Exp Biol Med (Maywood); 2015 Feb; 240(2):169-74. PubMed ID: 25245074 [TBL] [Abstract][Full Text] [Related]
18. Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy. Fall B; Scott CR; Mauer M; Shankland S; Pippin J; Jefferson JA; Wallace E; Warnock D; Najafian B PLoS One; 2016; 11(12):e0168346. PubMed ID: 27992580 [TBL] [Abstract][Full Text] [Related]
19. BDNF: mRNA expression in urine cells of patients with chronic kidney disease and its role in kidney function. Endlich N; Lange T; Kuhn J; Klemm P; Kotb AM; Siegerist F; Kindt F; Lindenmeyer MT; Cohen CD; Kuss AW; Nath N; Rettig R; Lendeckel U; Zimmermann U; Amann K; Stracke S; Endlich K J Cell Mol Med; 2018 Nov; 22(11):5265-5277. PubMed ID: 30133147 [TBL] [Abstract][Full Text] [Related]
20. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress. Raij L; Tian R; Wong JS; He JC; Campbell KN Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]